GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » PB Ratio

Bangkok Genomics Innovation PCL (BKK:BKGI) PB Ratio : 2.00 (As of Apr. 16, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-16), Bangkok Genomics Innovation PCL's share price is ฿1.79. Bangkok Genomics Innovation PCL's Book Value per Share for the quarter that ended in Dec. 2024 was ฿0.90. Hence, Bangkok Genomics Innovation PCL's PB Ratio of today is 2.00.

Good Sign:

Bangkok Genomics Innovation PCL stock PB Ratio (=1.9) is close to 2-year low of 1.9.

The historical rank and industry rank for Bangkok Genomics Innovation PCL's PB Ratio or its related term are showing as below:

BKK:BKGI' s PB Ratio Range Over the Past 10 Years
Min: 1.9   Med: 2.75   Max: 13.87
Current: 2

During the past 6 years, Bangkok Genomics Innovation PCL's highest PB Ratio was 13.87. The lowest was 1.90. And the median was 2.75.

BKK:BKGI's PB Ratio is ranked worse than
51.22% of 205 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.82 vs BKK:BKGI: 2.00

During the past 12 months, Bangkok Genomics Innovation PCL's average Book Value Per Share Growth Rate was 127.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 53.20% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Bangkok Genomics Innovation PCL was 75.30% per year. The lowest was 53.20% per year. And the median was 64.25% per year.

Back to Basics: PB Ratio


Bangkok Genomics Innovation PCL PB Ratio Historical Data

The historical data trend for Bangkok Genomics Innovation PCL's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Genomics Innovation PCL PB Ratio Chart

Bangkok Genomics Innovation PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial - - - - 2.46

Bangkok Genomics Innovation PCL Quarterly Data
Dec19 Dec20 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.08 2.96 3.41 2.46

Competitive Comparison of Bangkok Genomics Innovation PCL's PB Ratio

For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bangkok Genomics Innovation PCL's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's PB Ratio distribution charts can be found below:

* The bar in red indicates where Bangkok Genomics Innovation PCL's PB Ratio falls into.


;
;

Bangkok Genomics Innovation PCL PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Bangkok Genomics Innovation PCL's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=1.79/0.895
=2.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Bangkok Genomics Innovation PCL  (BKK:BKGI) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Bangkok Genomics Innovation PCL PB Ratio Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Genomics Innovation PCL Business Description

Traded in Other Exchanges
N/A
Address
3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Scientific testing services which generates key revenue, and Sale of goods.

Bangkok Genomics Innovation PCL Headlines